WRF
HAE icon

Waddell & Reed Financial’s Haemonetics HAE Stock Holding History

Waddell & Reed Financial’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$59.9M Sell
539,387
-129,056
-19% -$16M 0.12% 199
2020
Q4 		$79.4M Sell
668,443
-39,798
-6% -$4.28M 0.17% 166
2020
Q3 		$61.8M Sell
708,241
-31,438
-4% -$2.75M 0.15% 175
2020
Q2 		$66.2M Buy
739,679
+221,190
+43% +$22.3M 0.17% 152
2020
Q1 		$51.7M Buy
+518,489
New +$56.2M 0.17% 154

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Waddell & Reed Financial's HAE Position: Q1 2021 in Review

Waddell & Reed Financial reduced its Haemonetics (HAE) stake by 19% in Q1 2021, selling an estimated $16M and leaving 539,387 shares worth $59.9M. The position accounts for 0.12% of the portfolio, ranked #199.

Waddell & Reed Financial first reported a position in HAE in Q1 2020 and has held it in 5 quarters since. The position peaked at $79.4M in Q4 2020. 296 funds tracked by Wall St. Rank hold HAE as of Q1 2021.

  • Waddell & Reed Financial held 539,387 shares of Haemonetics worth $59.9M as of Q1 2021.
  • Waddell & Reed Financial sold 129,056 Haemonetics shares in Q1 2021, an estimated $16M.
  • Haemonetics made up 0.12% of Waddell & Reed Financial's portfolio in Q1 2021, its #199 holding.
  • Waddell & Reed Financial first reported a position in Haemonetics in Q1 2020 and has held it in 5 quarters since.
  • Waddell & Reed Financial's Haemonetics position peaked at $79.4M in Q4 2020.
  • 296 funds tracked by Wall St. Rank held Haemonetics as of Q1 2021.

Based on Waddell & Reed Financial's 13F filing for Q1 2021, filed 12 May 2021.